Skip to content

A study for immunostimulatory effects of intake of spore-forming lactic acid bacteria in adult men and women

A study for immunostimulatory effects of intake of spore-forming lactic acid bacteria in adult men and women - A study for immunostimulatory effects of intake of spore-forming lactic acid bacteria in adult men and women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042937
Enrollment
80
Registered
2021-01-08
Start date
2021-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Sponsors

TTC Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy working men and women between the ages of 20 and 64. (2) Those with low saliva s-IgA during screening. (3) Those who are prone to colds and flu. (4) Those who suffered from upper respiratory tract infections in the winter of the last two years. (5) Those who have received sufficient explanation of the purpose and content of this examination, have the ability to consent, and have volunteered to participate voluntarily after understanding well, who have agreed to participate in this examination in writing.

Exclusion criteria

Exclusion criteria: (1) Subjects having a disease or a history of serious diseases for which medication was required. (2) Subjects who have chronic diseases and use drugs. (3) Subjects who cannot stop the consumption of foods containing the components involved in test foods during the study period. (4) Subjects who routinely use health food containing involvement ingredients. (5) Subjects who get treatment affecting the test results. (6) Subjects who cannot abstinence from 2 days before the inspection. (7) Subjects having possibilities for emerging allergy related to the study. (8) Subjects who have a history of digestive disorders and digestive surgery that affect digestion and absorption. (9) Subjects who have experienced abnormal clinical test values or cardiopulmonary function and have been judged to have problems participating in the study. (10) Subjects who have a history of drug dependence, alcohol dependence, or current medical history. (11) Subjects who are prone to diarrhea when consuming dairy products. (12) Night and day shift worker or manual laborer. (13) Subjects who are or plan to perform dental care one month prior to pre-examination, currently, or during the study period. (14) Subjects who have oral or dental problems with bleeding or develops the trouble. (15) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination. (16) Subjects who participated in other clinical studies and those who are willing to participate during the study period. (17) Subjects who are planned to become pregnant or lactating. (18) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (19) Subjects who are judged as unsuitable for the study by the investigator for other reason.

Design outcomes

Primary

MeasureTime frame
Physical condition questionnaire s-IgA (Saliva) IgA (Fecal)

Secondary

MeasureTime frame
POMS2 SF-36 Blood markers (Inflammation,Immune,Stress)

Countries

Japan

Contacts

Public ContactShingo Yamamichi

TTC Co., Ltd. Clinical Research Planning Department

yamamichi578@eps.co.jp03-5657-4983

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026